Assoc. Prof. MAZDAK GANJALI KHANI HAKEMI

Publication Network

Journal articles indexed in SCI, SSCI, and AHCI

Immune-dysregulation harnessing in myeloid neoplasms

Sharifi M. J., Xu L., Nasiri N., Ashja-Arvan M., Soleimanzadeh H., GANJALI KHANI HAKEMI M.

Cancer Medicine , vol.13, no.17, 2024 (SCI-Expanded)

An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy

Abdolmaleki S., GANJALI KHANI HAKEMI M., Ganjalikhany M. R.

PLoS ONE , vol.19, no.7 July, 2024 (SCI-Expanded)

Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model

Samman N., Mohabatkar H., Behbahani M., Ganjalı Khanı Hakemı M.

PLoS ONE , vol.19, no.6 June, 2024 (SCI-Expanded)

TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1

Shapourian H., Ghanadian M., Eskandari N., Shokouhi A., Demirel G. Y., Bazhin A. V., et al.

BMC CANCER , vol.24, no.1, 2024 (SCI-Expanded)

Bioactive peptides: an alternative therapeutic approach for cancer management

Ghadiri N., Javidan M., Sheikhi S., Taştan Ö., Parodi A., Liao Z., et al.

FRONTIERS IN IMMUNOLOGY , vol.15, 2024 (SCI-Expanded)

Editorial: Immunologic tumor microenvironment modulators for turning “cold” tumors to “hot” tumors

Ganjalı Khanı Hakemı M., Yanikkaya Demirel G., He X., Zeng C.

Frontiers in Immunology , vol.15, 2024 (SCI-Expanded)

PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia

Soltani M., Ghanadian M., Ghezelbash B., Shokouhi A., Zamyatnin A. A., Bazhin A. V., et al.

BMC Cancer , vol.23, no.1, 2023 (SCI-Expanded)

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)

Bakhtiari T., Ahmadvand M., Yaghmaie M., Sadeghi A., Mousavi S. A., Rostami T., et al.

BMC Immunology , vol.24, no.1, 2023 (SCI-Expanded)

TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines

Rezaei M., Ghanadian M., Ghezelbash B., Shokouhi A., Bazhin A. V., Zamyatnin A. A., et al.

FRONTIERS IN IMMUNOLOGY , vol.14, 2023 (SCI-Expanded)

PD-1/PD-L1 Interaction Regulates BCL2, KI67, BAX, and CASP3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid Leukemia

Soltani M., Vosoughi M., Ganjalikhani-Hakemi M., Shapoorian H., Beshkar P., Eskandari N., et al.

Iranian Journal of Allergy, Asthma and Immunology , vol.22, no.5, pp.495-503, 2023 (SCI-Expanded)

Morphology-Dependent Immunomodulatory Coating of Hydroxyapatite/PEO for Magnesium-Based Bone Implants

Farshid S., Kharaziha M., Salehi H., Ganjalikhani Hakemi M.

ACS APPLIED MATERIALS & INTERFACES , vol.15, no.42, pp.48996-49011, 2023 (SCI-Expanded)

Non-infectious meningitis and CNS demyelinating diseases: A conceptual review

Etemadifar M., Fereidan-Esfahani M., Sedaghat N., Kargaran P., Mansouri A., Abhari A., et al.

Revue Neurologique , vol.179, no.6, pp.533-547, 2023 (SCI-Expanded)

The role of miRNAs from mesenchymal stem/stromal cells-derived extracellular vesicles in neurological disorders

Jafarinia M., Farrokhi M. R., Ganjalikhani Hakemi M., Cho W. C.

Human Cell , vol.36, no.1, pp.62-75, 2023 (SCI-Expanded)

The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review

Bakhtiari T., Ahmadvand M., Salmaninejad A., Ghaderi A., Yaghmaie M., Sadeghi A., et al.

Current Cancer Drug Targets , vol.23, no.11, pp.868-878, 2023 (SCI-Expanded)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy

Ganjalikhani Hakemi M., Yanikkaya Demirel G., Li Y., Jayakumar N.

Frontiers in Immunology , vol.14, 2023 (SCI-Expanded)

Transplantation of human adipose-derived stem cells overexpressing LIF/IFN-β promotes recovery in experimental autoimmune encephalomyelitis (EAE)

Yousefi M., Nabipour A., Ganjalikhani Hakemi M., Ashja-Arvan M., Amirpour N., Salehi H.

Scientific Reports , vol.12, no.1, 2022 (SCI-Expanded) Sustainable Development

Potential role of autophagy induced by FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance: new insights

Zalpoor H., Bakhtiyari M., Akbari A., Aziziyan F., Shapourian H., Liaghat M., et al.

Cell Communication and Signaling , vol.20, no.1, 2022 (SCI-Expanded)

Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination with Checkpoint Inhibitors and Beyond

Soltani M., Savvateeva L. V., Ganjalikhani-Hakemi M., Zamyatnin A. A.

Current Drug Targets , vol.23, no.11, pp.1072-1084, 2022 (SCI-Expanded)

Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities

Rezaei M., Danilova N. D., Soltani M., Savvateeva L. V., Tarasov V. V., Ganjalikhani-Hakemi M., et al.

Current Cancer Drug Targets , vol.22, no.6, pp.437-453, 2022 (SCI-Expanded)

Quercetin potential effects against SARS-CoV-2 infection and COVID-19-associated cancer progression by inhibiting mTOR and hypoxia-inducible factor-1α (HIF-1α)

Zalpoor H., Bakhtiyari M., Liaghat M., Nabi-Afjadi M., Ganjalikhani-Hakemi M.

Phytotherapy Research , vol.36, no.7, pp.2679-2682, 2022 (SCI-Expanded)

Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality

Zalpoor H., Rezaei M., Yahyazadeh S., Ganjalikhani-Hakemi M.

Human Cell , vol.35, no.4, pp.1304-1305, 2022 (SCI-Expanded)

Molecular and immunochemical characterization of Pop n 2: A new allergen of Populus nigra pollen

Shams M., Assarehzadegan M., Eskandari N., Masjedi M., Kheirandish F., Ghasemi R., et al.

Clinical and Experimental Allergy , vol.51, no.12, pp.1613-1623, 2021 (SCI-Expanded)

Mrna-based cancer vaccines: A therapeutic strategy for the treatment of melanoma patients

Bidram M., Zhao Y., Shebardina N. G., Baldin A. V., Bazhin A. V., Ganjalikhany M. R., et al.

Vaccines , vol.9, no.10, 2021 (SCI-Expanded)

Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer

Aria H., Ghaedrahmati F., Ganjalikhani-Hakemi M.

Journal of Cellular Physiology , vol.236, no.9, pp.6168-6189, 2021 (SCI-Expanded)

Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected-macrophages activation

Katebi A., Varshochian R., Riazi-rad F., Ganjalikhani-Hakemi M., Ajdary S.

Biomedicine and Pharmacotherapy , vol.137, 2021 (SCI-Expanded)

“NMDA receptor spectrum disorder” in the differential diagnosis of demyelinating disorders of the CNS: optic neuritis and myelitis

Etemadifar M., Abhari A. P., Sabeti F., Ganjalikhani-Hakemi M., Salari M., Hashemi F., et al.

Neurological Sciences , vol.42, no.1, pp.151-157, 2021 (SCI-Expanded)

Liver Resection Promotes (Regulates) Proinflammatory Cytokines in Patients with Hepatocellular Carcinoma

Fathi F., Sanei B., Ganjalikhani Hakemi M., Saidi R. F., Rezaei A.

Canadian Journal of Gastroenterology and Hepatology , vol.2021, 2021 (SCI-Expanded)

Anti-allergic effects of vitamin E in allergic diseases: An updated review

Shams M., Jafari R., Eskandari N., Masjedi M., Kheirandish F., Ganjalikhani Hakemi M., et al.

International Immunopharmacology , vol.90, 2021 (SCI-Expanded)

Modulation of Th17 Proliferation and IL-17A Gene Expression by Acetylated Form of Apigenin in Patients with Multiple Sclerosis

Rahmati M., Ghannadian S. M., Kasiri N., Ahmadi L., Motedayyen H., Shaygannejad V., et al.

Immunological Investigations , vol.50, no.2-3, pp.216-229, 2021 (SCI-Expanded)

Computational study for suppression of CD25/IL-2 interaction

Dehbashi M., Hojati Z., Motovali-Bashi M., Ganjalikhani-Hakemi M., Shimosaka A., Cho W. C.

Biological Chemistry , vol.402, no.2, pp.167-178, 2021 (SCI-Expanded)

The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?

Ganjalikhani Hakemi M., Jafarinia M., Azizi M., Rezaeepoor M., Isayev O., Bazhin A. V.

Frontiers in Oncology , vol.10, 2020 (SCI-Expanded)

Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis

Jafarinia M., Alsahebfosoul F., Salehi H., Eskandari N., Azimzadeh M., Mahmoodi M., et al.

Journal of Cellular Physiology , vol.235, no.11, pp.8779-8790, 2020 (SCI-Expanded)

Impact of IFN-β and LIF overexpression on human adipose-derived stem cells properties

Ashja-Arvan M., Dehbashi M., Eslami A., Salehi H., Yoosefi M., Ganjalikhani-Hakemi M.

Journal of Cellular Physiology , vol.235, no.11, pp.8736-8746, 2020 (SCI-Expanded)

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy

Jafarinia M., Alsahebfosoul F., Salehi H., Eskandari N., Ganjalikhani-Hakemi M.

Immunological Investigations , vol.49, no.7, pp.758-780, 2020 (SCI-Expanded)

Assessment of ability of human adipose derived stem cells for long term overexpression of IL-11 and IL-13 as therapeutic cytokines

Eslami A., Dehbashi M., Ashja-Arvan M., Salehi H., Azimzadeh M., Ganjalikhani-Hakemi M.

Cytotechnology , vol.72, no.5, pp.773-784, 2020 (SCI-Expanded)

The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice

Azimzadeh M., Mahmoodi M., Kazemi M., Hakemi M., Jafarinia M., Eslami A., et al.

International Immunopharmacology , vol.87, 2020 (SCI-Expanded)

Knocking down of the DHFR-TS gene in Toxoplasma gondii using siRNA and assessing the subsequences on toxoplasmosis in mice

Azimi-Resketi M., Eskandarian A., Ganjalikhani-Hakemi M., Zohrabi T.

Acta Tropica , vol.207, 2020 (SCI-Expanded)

Quercetin with the potential effect on allergic diseases

Jafarinia M., Sadat Hosseini M., Kasiri N., Fazel N., Fathi F., Ganjalikhani Hakemi M., et al.

Allergy, Asthma and Clinical Immunology , vol.16, no.1, 2020 (SCI-Expanded)

Induction of humoral immune responses and inhibition of metastasis in mice by a VEGF peptide-based vaccine

Gharibdousti F. S., Gharibdousti F. S., Delshad B. F., Delshad B. F., Falak R., Shayanfar N., et al.

Iranian Journal of Basic Medical Sciences , vol.23, no.4, pp.507-514, 2020 (SCI-Expanded)

Increased Expression of B Lymphocyte Induced Maturation Protein 1 (BLIMP1) in Patients with Common Variable Immunodeficiency (CVID)

Farrokhi S., Abbasi-Rad F., Esmaeil N., Sherkat R., Yazdani R., Afshar-Ghasemlou S., et al.

Iranian Journal of Allergy, Asthma and Immunology , vol.19, no.4, pp.437-446, 2020 (SCI-Expanded)

Correlation of OX40 ligand on B cells with serum total IgE and IL-4 levels by CD4 + T cells in allergic rhinitis

Fouladi S., Masjedi M., G. Hakemi M., Ghasemi R., Eskandari N.

Allergologia et Immunopathologia , vol.47, no.3, pp.234-240, 2019 (SCI-Expanded)

MicroRNA-92a Drives Th1 Responses in the Experimental Autoimmune Encephalomyelitis

Rezaei N., Talebi F., Ghorbani S., Rezaei A., Esmaeili A., Noorbakhsh F., et al.

Inflammation , vol.42, no.1, pp.235-245, 2019 (SCI-Expanded)

The review of in vitro and in vivo studies over the glycyrrhizic acid as natural remedy option for treatment of allergic asthma

Fouladi S., Masjedi M., Hakemi M., Eskandari N.

Iranian Journal of Allergy, Asthma and Immunology , vol.18, no.1, pp.1-11, 2019 (SCI-Expanded)

Increased IRF4 expression in isolated B cells from common variable immunodeficiency (CVID) patients

Afshar-Ghasemlou S., Esmaeil N., Sherkat R., Yazdani R., Abbasi-Rad F., Ganjalikhani-Hakemi M., et al.

Allergologia et Immunopathologia , vol.47, no.1, pp.52-59, 2019 (SCI-Expanded)

Features and roles of T helper 9 cells and interleukin 9 in immunological diseases

Yazdani R., Shapoori S., Rezaeepoor M., Sanaei R., Ganjalikhani-Hakemi M., Azizi G., et al.

Allergologia et Immunopathologia , vol.47, no.1, pp.90-104, 2019 (SCI-Expanded)

The In Vitro Impact of Glycyrrhizic Acid on CD4+ T Lymphocytes through OX40 Receptor in the Patients with Allergic Rhinitis

Fouladi S., Masjedi M., Ghasemi R., G. Hakemi M., Eskandari N.

Inflammation , vol.41, no.5, pp.1690-1701, 2018 (SCI-Expanded)

Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease

Nekooie-Marnany N., Deswarte C., Ostadi V., Bagherpour B., Taleby E., Ganjalikhani-Hakemi M., et al.

Journal of Clinical Immunology , vol.38, no.7, pp.787-793, 2018 (SCI-Expanded)

Evaluation of the effect of TIM-3 suppression by miR-498 and its effect on apoptosis and proliferation rate of HL-60 cell line

Moghaddam Y., Andalib A., Mohammad-Ganji M., Homayouni V., Sharifi M., Ganjalikhani-Hakemi M.

Pathology Research and Practice , vol.214, no.9, pp.1482-1488, 2018 (SCI-Expanded)

Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients

Ghadiri N., Emamnia N., Ganjalikhani-Hakemi M., Ghaedi K., Etemadifar M., Salehi M., et al.

Gene , vol.659, pp.109-117, 2018 (SCI-Expanded)

Expressions of p53 and PUMA in fibroblasts of systemic sclerosis patients are normal at transcription level

Mahmoudi M. B., Abed Khojasteh M., Alsahebfosoul F., Gharibdoost F., Mostafaei S., Ganjalikhani-hakemi M., et al.

Journal of Cosmetic Dermatology , vol.17, no.3, pp.549-554, 2018 (SCI-Expanded)

Semaphorin-3A as An Immune Modulator Is Suppressed by MicroRNA-145-5p

Rezaeepoor M., Ganjalikhani-hakemi M., Shapoori S., Eskandari N., Sharifi M., Etemadifar M., et al.

Cell Journal , vol.20, no.1, pp.113-119, 2018 (SCI-Expanded)

Silencing of TIM-3 expression by miR-326 affects apoptosis and proliferation of human HL-60 leukemia cell line

Mohammad-Ganji M., Ganjalikhani-Hakemi M., Homayouni V., Rezaei A., Khanahmad H.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.28, no.2, pp.112-122, 2018 (SCI-Expanded)

The +4259A>C polymorphism of TIM-3 but not -1637C>T polymorphism of TIM-1 is associated with Multiple sclerosis in Isfahan population

Pouladian M., Ganjalikhani-Hakemi M., Alsahebfosul F., Homayouni V., Khosravi S., Etemadifar M., et al.

Multiple Sclerosis and Related Disorders , vol.18, pp.152-156, 2017 (SCI-Expanded)

The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro

Emamdoost F., Khanahmad H., Ganjalikhani-hakemi M., Doosti A.

Indian Journal of Hematology and Blood Transfusion , vol.33, no.3, pp.342-347, 2017 (SCI-Expanded)

Statistical support for Sema3A and multiple sclerosis

Rezaeepoor M., Shapoori S., Ganjalikhani-hakemi M., Etemadifar M., Alsahebfosoul F., Eskandari N., et al.

Gene , vol.626, pp.87-88, 2017 (SCI-Expanded)

Stimulation of camel polyclonal antibody against human T cell immunoglobulin and mucin 3

Homayouni V., Khanahmad H., Ganjalikhani-Hakemi M., Behdani M., Ghasemi P., Rezaei A.

Iranian Journal of Biotechnology , vol.15, no.3, pp.166-171, 2017 (SCI-Expanded)

Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients

Rezaeepoor M., Shapoori S., Ganjalikhani-hakemi M., Etemadifar M., Alsahebfosoul F., Eskandari N., et al.

Gene , vol.610, pp.59-63, 2017 (SCI-Expanded)

Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets

Yazdani R., Seify R., Ganjalikhani-Hakemi M., Abolhassani H., Eskandari N., Golsaz-Shirazi F., et al.

Allergologia et Immunopathologia , vol.45, no.2, pp.183-192, 2017 (SCI-Expanded)

Decreased Expression of B cell Maturation Antigen in Patients with Common Variable Immunodeficiency

Ansari M., Yazdani R., Sherkat R., Homayouni V., Ganjalikhani-Hakemi M., Rezaei A.

Pediatric, Allergy, Immunology, and Pulmonology , vol.30, no.1, pp.7-13, 2017 (SCI-Expanded)

The Effect of Licorice Protein Fractions on Proliferation and Apoptosis of Gastrointestinal Cancer Cell Lines

Khazraei-Moradian S., Ganjalikhani-Hakemi M., Andalib A., Yazdani R., Arasteh J., Kardar G. A.

Nutrition and Cancer , vol.69, no.2, pp.330-339, 2017 (SCI-Expanded)

Role of apoptosis in the pathogenesis of common variable immunodeficiency (CVID)

Ganjalikhani-Hakemi M., Yazdani R., Esmaeili M., Abolhassani H., Rae W., Azizi G., et al.

Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.17, no.4, pp.332-340, 2017 (SCI-Expanded)

The increase in protein and plasmid yields of e. Coli with optimized concentration of ampicillin as selection marker

Feizollahzadeh S., Kouhpayeh S., Rahimmansh I., Khanahmad H., Sabzehei F., Ganjalikhani-Hakemi M., et al.

Iranian Journal of Biotechnology , vol.15, no.2, pp.128-134, 2017 (SCI-Expanded)

Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency

Ganjalı Khanı Hakemı M.

CLINICAL IMMUNOLOGY , vol.175, pp.124-132, 2017 (SCI-Expanded)

Expression of biologically active murine interleukin-18 in Lactococcus lactis

Feizollahzadeh S., Khanahmad H., Rahimmanesh I., Ganjalikhani-Hakemi M., Andalib A., Sanei M. H., et al.

FEMS Microbiology Letters , vol.363, no.21, 2016 (SCI-Expanded)

Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)

Homayouni V., Ganjalikhani-Hakemi M., Rezaei A., Khanahmad H., Behdani M., Lomedasht F. K.

Iranian Journal of Basic Medical Sciences , vol.19, no.11, pp.1201-1208, 2016 (SCI-Expanded)

Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p

Fooladinezhad H., Khanahmad H., Ganjalikhani-Hakemi M., Doosti A.

British Journal of Biomedical Science , vol.73, no.3, pp.129-133, 2016 (SCI-Expanded)

Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan population

Mazrouei F., Ganjalikhani-Hakemi M., Salehi R., Alesahebfosoul F., Etemadifar M., Pouladian M., et al.

International Journal of Immunogenetics , vol.43, no.3, pp.131-134, 2016 (SCI-Expanded)

Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency

Yazdani R., Fatholahi M., Ganjalikhani-Hakemi M., Abolhassani H., Azizi G., Hamid K. M., et al.

Molecular Immunology , vol.71, pp.1-9, 2016 (SCI-Expanded)

Characteristics of innate lymphoid cells (ILCs) and their role in immunological disorders (an update)

Yazdani R., Sharifi M., Shirvan A. S., Azizi G., Ganjalikhani-Hakemi M.

Cellular Immunology , vol.298, no.1-2, pp.66-76, 2015 (SCI-Expanded)

Development of a stable cell line, overexpressing human T-cell immunoglobulin mucin 1

Ebrahimi M., Kazemi T., Ganjalikhani-Hakemi M., Majidi J., Khanahmad H., Rahimmanesh I., et al.

Iranian Journal of Biotechnology , vol.13, no.4, 2015 (SCI-Expanded)

Association analysis of -416 G>C polymorphism of T-cell immunoglobulin and mucin domain-1 gene with asthma in Iran

Shirzade H., Meshkat R., Ganjalikhani-Hakemi M., Mosayebian A., Ghasemi R., Deress F., et al.

International Journal of Immunogenetics , vol.42, no.4, pp.265-269, 2015 (SCI-Expanded)

miR-141 and miR-200a, revelation of new possible players in modulation of Th17/Treg differentiation and pathogenesis of multiple sclerosis

Naghavian R., Ghaedi K., Kiani-Esfahani A., Ganjalikhani-Hakemi M., Etemadifar M., Nasr-Esfahani M. H.

PLoS ONE , vol.10, no.5, 2015 (SCI-Expanded)

Articles Published in Other Journals

Potential Diagnostic Value of Abnormal Pyroptosis Genes Expression in Myelodysplastic Syndromes (MDS): A Primary Observational Cohort Study.

Soltani M., Sharifi M. J., Khalilian P., Sharifi M., Nematollahi P., Shapourian H., et al.

International journal of hematology-oncology and stem cell research , vol.18, no.2, pp.156-164, 2024 (Scopus)

Nanoparticles as Potent Agents for Treatment of Schistosoma Infections: A Systematic Review

Shakib P., Zivdari M., Khalaf A. K., Marzban A., Ganjalikhani-Hakemi M., Parvaneh J., et al.

Current Therapeutic Research - Clinical and Experimental , vol.99, 2023 (ESCI)

Evaluation of Silencing Effect of miR-133a-5p Mimic on TIM-3 Expression in AML (HL-60) Cell Line

Hojati Z., Ganjalikhani-Hakemi M., Ameri M., Alimohammadi-Jelodar S. F., Dehbashi M., Mohammad Ganji M., et al.

Indian Journal of Clinical Biochemistry , vol.35, no.3, pp.359-366, 2020 (ESCI)

The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer

Andalib A., Rashed S., Dehbashi M., Hajati J., Noorbakhsh F., Ganjalikhani-Hakemi M.

Indian Journal of Clinical Biochemistry , vol.35, no.3, pp.312-321, 2020 (ESCI)

Outcome of corneal collagen cross-linking in keratoconus: Introducing the predictive factors

Peyman A., Feizi A., Ganjalikhani-Hakemi M., Hosseini-Nasab F., Pourazizi M.

Journal of Current Ophthalmology , vol.32, no.1, pp.19-25, 2020 (ESCI)

Optimization of in vitro expansion and activation of human natural killer cells against breast cancer cell line

Peighambarzadeh F., Najafalizadeh A., Esmaeil N., Rezaei A., Ashrafi F., Hakemi M.

AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY , vol.12, pp.17-23, 2020 (Scopus)

Negative regulation of semaphorin-3A expression in peripheral blood mononuclear cells using microRNA-497-5P

Shapoori S., Ganjalikhani-Hakemi M., Rezaeepoor M., Alsahebfosoul F., Khosravi S., Etemadifar M., et al.

Iranian Journal of Medical Sciences , vol.44, no.4, pp.325-333, 2019 (Scopus)

Integral membrane protein expression of human CD25 on the cell surface of HEK293 cell line: The available cellular model of CD25 positive to facilitate in vitro developing assays

Dehbashi M., Hojati Z., Motovali-Bashi M., Ganjalikhani-Hakemi M., Shimosaka A.

Biomolecular Concepts , vol.10, no.1, pp.150-159, 2019 (Scopus)

Exons analysis of interferon-gamma receptor 1 gene in patients with Mendelian susceptibility to mycobacterial diseases (MSMD) in the central region of Iran

Sherkat R., Yaran M., Nekooei N., Talebi E., Rahimi H., Bagherpoor B., et al.

Journal of Isfahan Medical School , vol.36, no.503, pp.1349-1354, 2019 (Scopus)

Recurrent vulvovaginal candidiasis: Could it be related to cell-mediated immunity defect in response to Candida antigen?

Talaei Z., Sheikhbahaei S., Ostadi V., Hakemi M., Meidani M., Naghshineh E., et al.

International Journal of Fertility and Sterility , vol.11, no.3, pp.134-141, 2017 (Scopus)

Inhibitory effect of genistein on PLC/PRF5 hepatocellular carcinoma cell line

Dastjerdi M. N., Kavoosi F., Valiani A., Esfandiari E., Sanaei M., Sobhanian S., et al.

International Journal of Preventive Medicine , vol.2015-june, 2015 (Scopus)

Molecular cloning and expression of novel fibroblast growth factor-2 conjugated with immunodominant domains of pseudomonas exotoxin

Haghighatfard H., Samaei N. M., Farazmandfar T., Hakemi M., Yamchi A., Jadidi-Niaragh F., et al.

Biomedical and Pharmacology Journal , vol.8, no.2, pp.1195-1200, 2015 (Scopus)

Metrics

Publication

Citation (WoS)

1602

H-Index (WoS)

Citation (Scopus)

1556

H-Index (Scopus)

Citation (Scholar)

2374

H-Index (Scholar)

Open Access

UN Sustainable Development Goals

Publications & Works